Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Kisspeptin-10
evidence profile

Synthetic or endogenous C-terminal kisspeptin decapeptide and KISS1R/GPR54 agonist. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Kisspeptin-10: conceptual scientific illustration for Reproductive Endocrinology
VISUAL GUIDE · Kisspeptin-10

Reproductive Endocrinology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A KISS1-derived C-terminal decapeptide that can stimulate GnRH-linked reproductive-hormone responses. Small endocrine studies do not establish treatment efficacy for hypogonadism, fertility, libido or weight loss, and it is not a component of an FDA-approved drug.

01

ENTITY FACTS

What should readers identify first?

MOLECULEKisspeptin-10
PHARMACOLOGYSynthetic or endogenous C-terminal kisspeptin decapeptide and KISS1R/GPR54 agonist
PRIMECORE CLASSC
EVIDENCE GRADEC
RESEARCH TOPICReproductive Endocrinology
LAST REVIEWED2026-08-29

What remains unknown?

Insufficient data in the current dataset

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. https://www.fda.gov/media/182089/download
  2. https://www.fda.gov/media/185414/download
  3. https://precision.fda.gov/ginas/app/ui/substances/06b53a1a-3415-4d25-8d7c-0cedb1006eb7
  4. https://pubmed.ncbi.nlm.nih.gov/21632807/
  5. https://pubmed.ncbi.nlm.nih.gov/23153270/
  6. https://pubmed.ncbi.nlm.nih.gov/42549827/
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Kisspeptin-10?

Kisspeptin-10 is described pharmacologically as Synthetic or endogenous C-terminal kisspeptin decapeptide and KISS1R/GPR54 agonist. A KISS1-derived C-terminal decapeptide that can stimulate GnRH-linked reproductive-hormone responses. Small endocrine studies do not establish treatment efficacy for hypogonadism, fertility, libido or weight loss, and it is not a component of an FDA-approved drug.

Does Kisspeptin-10 have strong evidence?

PrimeCoreBio records Evidence Grade C. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Kisspeptin-10 approved everywhere?

No global conclusion should be inferred. PrimeCore Class C must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice